| 000 | 00999 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517060457.0 | ||
| 264 | 0 | _c20160729 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a1744-8042 | ||
| 024 | 7 |
_a10.2217/pgs.15.114 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFrancies, Hayley E | |
| 245 | 0 | 0 |
_aWhat role could organoids play in the personalization of cancer treatment? _h[electronic resource] |
| 260 |
_bPharmacogenomics _c2015 |
||
| 300 |
_a1523-6 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aOrganoids _xdrug effects |
| 650 | 0 | 4 |
_aPrecision Medicine _xtrends |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aGarnett, Mathew J | |
| 773 | 0 |
_tPharmacogenomics _gvol. 16 _gno. 14 _gp. 1523-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2217/pgs.15.114 _zAvailable from publisher's website |
| 999 |
_c25371678 _d25371678 |
||